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Introduction 
Idiopathic generalized epilepsies (IGEs) are character-
ized by recurring generalized seizures without any un-
derlying structural cerebral lesion or other neurological 
finding1 and comprise approximately70% of  all epilep-
sy cases2.
According to the classification by the International 
League Against Epilepsy (ILAE), “idiopathic epilepsy 
(IE) syndrome is an age-dependent, pure epilepsy syn-
drome of  predominately genetic origin in which there is 
no underlying anatomic or neurological abnormality”3.
Numerous studies have assumed that genetic defects 
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play an essential role in the etiology of  IGEs, and it has 
been reported that many IGE-related genes are respon-
sible for encoding canal proteins4. 
Recent studies indicated that the molecular mechanisms 
underlying the IGEs are mutations in some critical ion 
and non-ion channel protein encoding genes. Muta-
tions in ME2, LGI4, EFHC1, and EFHC2, which en-
code non-ion channel proteins and KCNJ10, KCNJ3, 
KCNQ2/KCNQ3, CLCN2, GABRG2, GABRA1, SC-
N1B, and SCN1A, which encode ion channel proteins 
have been implicated in epilepsy2.
The EFHC2 gene is mapped to chromosome Xp11.4; 
it contains 15 exons and encodes a 749-amino acid 
protein, and contains three DM10 domains and three 
calcium-binding EF-hand motives5. DM10-1 domain 
is located between amino acids 75-182 (108 amino ac-
ids), while the 143-amino acid containing DM10-2 and 
108-amino acid containing DM10-3 domains are locat-
ed between amino acids 226-368 and 431-538, respec-
tively. The 36-amino acid containing EF-hand domain 
is located at a region within amino acids 558-593. Alter-
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native splicing produces two isoforms of  the protein. 
The second isoform is a 162-amino acid product with-
out the amino acids 1-5876.
Gu et al. reported a tentative relation between the 
S430Y polymorphism of  EFHC2 gene in patients suf-
fering from Juvenile Myoclonic Epilepsy (JME), an 
IGE sub syndrome, and epilepsy. They emphasized that 
independent replication studies are required to further 
analyse the relation between S430Y polymorphism and 
IGE5. In this study, we have examined whether there 
is relation between S430Y polymorphism of  EFHC2 
gene and IGE.
Materıal and methods
Patient and control groups
Patient group: 42 male and 54 female patients, mean 
aged 31.35, diagnosed clinically with IGE at the De-
partment of  Neurology of  Faculty of  Medicine, Celal 
Bayar University were included in the study. In terms 
of  seizure type, patients with IGE (n = 96) were ton-
ic-clonic (n = 77), absence (n = 8), tonic (n = 4), atonic 
(n = 3), myoclonic (n = 4). All patients gave fully in-
formed consents to participate in the study, and 3 mL 
of  a blood sample was taken from each of  them.
Control group: 46 male and 50 female patients, mean 
aged 34.90, who presented to the Department of  Neu-
rology but did not have epilepsy or a condition which 
epilepsy-related genes are implicated comprised the 
control group. All control subjects gave fully informed 
consents to participate in the study, and 3 mL of  blood 
samples were taken from them.
Genomic DNA isolation
Genomic DNA isolation was carried out in accord-
ance with the manufacturer's protocol using 3 mL 
blood drawn from the subjects into collection tubes 
with EDTA (High Pure PCR Template Preparation Kit 
Ref# 11 796 828 001 Roche Diagnostics GmbH, Man-
nheim, Germany). 
 
Analysis of  S430Y polymorphism in EFHC2 Gene 
by real-time PCR
Using the extracted DNA, the design of  the primers 
and probes used for the analysis of  G/T base substi-
tution causing amino acid exchange S430Y in EFHC2 
was undertaken by a commercial company (TIB MOL-
BIOL GmbH, Berlin, Germany)  (Table1). 
Table 1: Primers and hybridization probes used to determine the  
S430Y polymorphism in EFHC2 gene 
 
Forward primer rs2208592F TGAAATGGTGTCATCACCGAGATA 





Absorbance probe at 640 






            * FL: Labeled with fluorescent from 3’ end 
            **640 : Labeled with LightCycler Red 640 (LC Red 640) from 5’ end 
LightCycler Faststart DNA Master Probe mix was ob-
tained from a commercial company (Ref# 03 003 248 
001 Roche Diagnostics GmbH, Mannheim, Germany).
PCR mix was prepared for the PCR reaction. PCR mix 
with a final volume of  20 µl included 2µl forward prim-
er (0.5µM at 1x concentration), 2µl reverse primer (0.5 
µM at 1x concentration), 2µl fluorescent-labeled probe 
(0.2 µM at 1x concentration), 2µl LC Red 640 labeled 
probe (0.2 µM at 1x concentration), 2µl Taq DNA Poly-
merase(1x), 3.4 µl distilled water (H2O, PCR grade), 1.6 
µl MgCl2 (3mM at 1x concentration) and 5µl genomic 
template DNA (5-25 ng/µl). PCR reaction conditions 
are presented in Table 2. Melting curve analysis was 
gathered by LightCycler Software 3.05.  
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Statistical analysis
Student T test was used to compare the difference in 
mean ages between the patient and control groups. Chi-
square test and Fisher’s Exact Test were used for com-
parison of  parameters related to G>T polymorphism 
that caused amino acid exchange S430Y, for sex distri-
bution and for within-group comparison of  the data 
obtained from the patient group. The level of  signifi-
cance was set at p<0.05 for both tests.
Results
Genotyping
Three different genotypes emerge when serine is sub-
stituted with tyrosine at position 430 (S430Y) as a result 
of  G>T exchange at nucleotide 1289 of  EFHC2 gene. 
Subjects with G/G genotype (wild type) were normal, 
those with G/T genotype were heterozygote, and those 
with T/T genotype were homozygote. EFHC2 is a gene 
found at X chromosome (Xp11.4). 
While genotyping, hemizygote males with G>T pol-
ymorphism were considered homozygote since males 
have a single X chromosome. 








Temperature (oc) Duration 
Pre-incubation (To 




95 10 minutes 
PCR cycle 45 
Denaturation 95 10 seconds 
Annealing 58 10 seconds * 
Extension 72 15 seconds 
Melting analysis (to 
determine SNP) 1 
Denaturation 95      0 second 
Annealing 40 30 seconds 
Melting 85  0 second** 
Cooling 1   40 30 seconds 
        * Single reading is taken to observe the amplification curve. 
          **Continuous reading with 0.2 0C/sec ramp rate. 
 
Figure 1: The results of Melting curve analysis that enabled genotyping using Light Cycler 
hybridization probe system and LC-Red 640 hybridization probe. 
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According to the melting curve, the fluorescence signal 
is detected at 57oC for G and at 63.5oC for T. Genotyp-
ing is presented in Figure 1.
Statistical analysis
Table 3 depicts the data pertaining to the 96 patients di
agnosed with IGE and 96 subjects in the control group.
Table 3: Parameters compared between patients and controls 
 
  Control Patient 
n 96 (100%) 96 (100%) 
      
Sex     
                  Male 46 (48%) 41 (43%) 
                  Female 50 (52%) 55 (57%) 
      
Mean age (years) 34.90 31.35 
      
S430y genotype     
                 Normal 84 (88%) 83 (87%) 
                 Heterozygote  8 (8%) 7 (7%) 
                 Homozygote 4 (4%) 6 (6%) 
 
Age, sex, type of  IGE seizure, age at first seizure, family history of  epilepsy and genotypes related to S430Y pol-
ymorphism in EFHC2 gene are presented in Table 4. 
Table 4: Data related to the Patient Group 
 
Patient group 
N (number of subjects) 96 (100%) 
  
Sex   
                  Male 41 (47%) 
                  Female 55 (53%) 
Mean age (years)                   31.35  
Type of seizure   
                 Tonic clonic 77 (81%) 
                 Absence 8 (8%) 
                 Tonic 4 (4%) 
                 Atonic 3 (3%) 
                 Myoclonic 4 (4%) 
Family history of epilepsy   
                 Present 17 (18%) 
                 Absent 79 (82%) 
Age at first seizure (x)   
                X≤16 42 (44%) 
                X>16 54 (56%) 
S430y genotype   
                 Normal (g/g) 83 (87%) 
                 Heterozygote (g/t) 7 (7%) 
                 Homozygote (t/t) 6 (6%) 
  
Subjects in the patient group were divided into 3 groups 
in terms of  age, namely “39 and under” “between 40-
59” and“60 and over”. The relation between age group 
and type of  seizure was assessed by Chi-square test and 
no significant relation was found (p>0.05) (Table 5). 
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Table 5: Type of seizures with respect to age groups 
 
  Type of ige seizure   
Age group Tonic 
clonic 

















































Presence of  a relation between the type of  IGE seizure 
in the Patient Group and S430Y polymorphism geno-
type was tested by chi-square test, and we found that 
the difference was not statistically significant (p>0.05) 
(Table 6).
Table 6: The distribution of types of IGE seizures with respect to the S430Y genotype 
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(71.4%) 
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The genes calcium-binding EF-hand motifs 1 (EFHC1) 
and 2 (EFHC2) are responsible for the encoding of  
non-ion channel proteins which have been suggested 
to interact with ion channels, and hence they are asso-
ciated with the development of  epilepsy. Especially the 
amino acid exchange S430Y in exon 9 of  EFHC2 was 
investigated in JME patients5. When the data obtained 
from our study was compared statistically, the differ-
ences between patient and control groups were found 
not to be significant (p>0.05).
However, due to the chromosomal location of  the 
gene, male and female patients should be assessed sep-
arately in terms of  S430Y polymorphism. Even though 
X chromosomal inheritance has not been identified 
among the complex genetic trait model of  IGE syn-
dromes, presence of  a single X chromosome in males 
should be taken into consideration.
In German population, Gu and colleagues5 determined 
the polymorphisms in EFHC2 gene and their localiza-
tions. Also, authors reported a weak relation between 
S430Y (rs2208592) missense mutation and the epilep-
sy in 81 patients diagnosed with classical JME (without 
absence seizure), and they argued that S430Y polymor-
phism affected seizure susceptibility in male patients 
with JME5. In our study, 12 subjects in the control 
group (4 males and 8 females) and 13 patients (5 males 
and 8 females) in the patient group had S430Y poly-
morphism. When the control and patient groups were 
compared in terms of  sex and presence of  S430Y pol-
ymorphism, the differences were not statistically signif-
icant (p>0.05).
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Types of  seizures observed in IGE are tonic-clonic, 
myoclonic, atonic, tonic and absence seizures. Simi-
lar to generalized epilepsy with febrile seizures plus 
(GEFS+), fever may also accompany seizures in some 
forms of  IGE7. 
It has been argued that some genes involved in IGE 
had influence on the type of  seizure as well. KCN1A8 
and KCNJ109, two of  the ion-channel genes, could be 
risk factors for seizure even though these genes did not 
have a major effect on the development of  epilepsy. 
In the present study, among the 96 IGE patients, 77 had 
tonic-clonic, 8 had absence, 4 had tonic, 3 had atonic 
and 4 had myoclonic seizure. There was no statistically 
significant relation between the type of  seizure and car-
rier state for S430Y polymorphisms in EFHC2 in the 
patient group (p>0.05). 
In a previous study5, absence of  a significant relation 
between JME and S430Y G>T polymorphism can be 
attributed to the presence of  only 4 cases with JME 
during patient recruitment phase. Investigating S430Y 
amino acid exchange only in the JME group could yield 
different findings.
EFHC2 is the EFHC1 gene paralog in human genome. 
EFHC1 and EFHC 2 genes are expressed in cerebral 
neurons5. In our previous study, we found no evidence 
that EFHC1 is a major genetic factor for the develop-
ment of  IGE in Turkish patients, and we indicated that 
685T>C and 662G>A polymorphisms might not be 
associated with IGE10. Hence, we considered that ex-
amined polymorphisms (in genes EFHC1 and EFHC2) 
might not be a major genetic risk factor in terms of  
IGE.
Data pertaining to the SNP that causes S430Y exchange 
(rs2208592) can be found at the web pages of  Nation-
al Institute of  Health Sciences11. This page lists S430Y 
genotype data obtained from 1245 patients from Asia, 
Europe, Africa, and various populations, and it shows 
that 956 patients had G/G, 71 had G/T, and 30 had 
T/T genotype11. In our study, of  the 96 patients, 83 had 
G/G, 7 had G/T and 6 had T/T genotype, while 84 of  
96 subjects in the control group had G/G, 8 had G/T, 
and 4 had T/T genotype. Being the first published data 
on S430Y polymorphism in Turkish population, we be-
lieve that the results of  the present study will contribute 
to the knowledge base.
 
Conclusion
Present study in which the relation between idiopathic 
generalized epilepsy and G>T polymorphism resulting 
in S430Y amino acid exchange in EFHC2 is examined, 
one of  the non-ion channel genes failed to show a sta-
tistically significant difference between the patient and 
control groups.
The data on S430Y polymorphism genotypes in IGE 
patients and control subjects in  Turkish population 
determined by real time PCR is the first of  its kind. 
Data obtained in this study has the potential to set the 
ground for future studies.
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